If you wish to receive Everest Medicines Limited information by email, please choose your options for email notification, enter your email address and information below and click "Submit".
2021-10-22
NEXT DAY DISCLOSURE RETURN
2021-10-06
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED SEPTEMBER 30
2021-10-04
NEXT DAY DISCLOSURE RETURN
2021-09-30
SUPPLEMENTAL ANNOUNCEMENT UPDATE IN RELATION TO DISCLOSEABLE TRANSACTION
2021-09-29
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE SUBMISSION OF NEW DRUG APPLICATION IN HONG KONG FOR XERAVATM FOR THE TREATMENT OF COMPLICATED INTRA-ABDOMINAL INFECTIONS
2021-09-24
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON THE APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION BY CHINA NMPA FOR SPR206
2021-09-23
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON MULTI-TARGET COLLABORATION WITH ABCELLERA BIOLOGICS INC. TO ADVANCE NEW ANTIBODAY THERAPIES
2021-09-17
DISCLOSEABLE TRANSACTION LICENSE AGREEMENT FOR GLOBAL DEVELOPMENT, MANUFACTURING AND COMMERCIALIZATION OF NOVEL BTK INHIBITOR IN RENAL DISEASES
2021-09-14
SUPPLEMENTAL AND CLARIFICATION ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION
2021-09-13
DISCLOSEABLE TRANSACTION (1) COVID-19 VACCINES LICENSE AGREEMENT; (2) COLLABORATION AND LICENSE AGREEMENT; AND (3) SHARE ISSUANCE AGREEMENT IN RESPECT OF THE MANUFACTURE, DEVELOPMENT AND COMMERCIALIZATION OF COVID-19 VACCINES AND CERTAIN LICENSED PRODUCTS
